Cardiac involvement is one of the main complications substantially contributing to the morbidity and mortality of patients suffering from systemic lupus erythematous (SLE). However, clinically important myocarditis is an unusual feature in SLE. We describe the clinical characteristics, management, and outcome of a 15-year young girl with SLE who developed severe left ventricular dysfunction.
Wijetunga M, Rockson S. Myocarditis in systemic lupus erythematosus (review). Am J Med 2002;113:419-23.
Szekanecz Z, Shoenfeld Y. Lupus and cardiovascular disease: The facts. Lupus 2006;15S:3-10.
Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Cardiovascular involvement in systemic lupus erythematous. Lupus 2005;14:683-6.
Woo SI, Hwang GS, Kang SJ, Park JS, Park SJ, Lee YS, et al. Lupus myocarditis presenting as acute congestive heart failure: A case report. J Korean Med Sci 2009;24:176-8.
Gupta A, Singh S, Minz RW, Radotra BD. Lupus myocarditis in children. Ann Rheum Dis 2004;63:745-6.
Frustaci A, Gentiloni N, Caldarulo M. Acute myocarditis and left ventricular aneurysm as presentations of systemic lupus erythematous. Chest 1996;109:282-4.
Naarendorp M, Kerr LD, Khan AS, Omstein MH. Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patient with acute cardiomyopathy: Report of 6 cases. J Rheumatol 1999;26:2257-60.
Chan YK, Li EK, Tam LS, Chow LT, Ng HK. Intravenous cyclophosphamide improves cardiac dysfunction in lupus myocarditis. Scan J Rheumatol 2003;32:306-8.
Sherer Y, Levy Y, Shoenfeld Y. Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 1999;18:238-40.
Apte M, McGwin G Jr, Vilα LM, Kaslow RA, Alarcσn GS, Reveille JD. Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (LV). Rheumatology 2008;47:362-7.